Financial Performance - Revenue increased to $23.3 billion in 3Q25 from $17.8 billion in 3Q24[7] - Operating margin improved from -32.3% in 3Q24 to -20.5% in 3Q25[7] - Core loss per share improved from ($10.44) in 3Q24 to ($7.47) in 3Q25[7] - Free cash flow turned positive, reaching $0.2 billion in 3Q25 compared to ($2.0 billion) in 3Q24[7] Segment Performance - Commercial Airplanes revenue increased to $11.1 billion in 3Q25 from $7.4 billion in 3Q24, but operating margin remained negative at -48.3%[10] - Defense, Space & Security revenue increased to $6.9 billion in 3Q25 from $5.5 billion in 3Q24, with operating margin turning positive to 1.7%[13] - Global Services revenue increased to $5.4 billion in 3Q25 from $4.9 billion in 3Q24, with a strong operating margin of 17.5%[16] Backlog and Production - Commercial Airplanes backlog stands at $535 billion, representing over 5,900 airplanes[11] - Defense, Space & Security orders valued at $9 billion, with a backlog of $76 billion[14] - Global Services orders valued at $8 billion, with a backlog of $25 billion[17] Cash and Debt - Cash and marketable securities remained stable at $23.0 billion[19] - Consolidated debt slightly increased to $53.4 billion[21]

Company Overview - TETRA's market capitalization is $105 billion as of October 24, 2025[14] - The company's net debt is $114 million as of September 30, 2025[14] - The enterprise value is $117 billion as of October 24, 2025[14] - Q3 2025 TTM revenue is $619 million, with an adjusted EBITDA margin of 187%[15,21] Financial Performance and Targets - 2024 revenue was $599 million, with adjusted EBITDA of $994 million[20] - 2025 revenue guidance is $620-630 million, with adjusted EBITDA of $107-112 million[20] - The company targets 2030 revenue of $125 billion, representing a 15% CAGR, and adjusted EBITDA of $325 million, with a 26% adjusted EBITDA margin[146] Business Segments and Growth - Completion Fluids & Products revenue is $362 million TTM, with an adjusted EBITDA margin of 331%[15,41] - Water & Flowback Services revenue is $257 million TTM, with an adjusted EBITDA margin of 121%[15] - The company is transitioning to three future segments: Energy Services, Specialty Chemicals & Minerals, and Water Treatment & Desalination[27] Critical Minerals and Bromine Project - TETRA has over 40000 acres of mineral-rich Smackover brine leases[115] - The Arkansas Bromine Project has a projected incremental revenue of $230 million and incremental EBITDA of $105 million at full production[124] - The Arkansas Bromine Project has a project capex of $270 million, an NPV10 of $710 million, and an IRR of 62%[124]

Financial Performance - Consolidated sales decreased by 19% to $130.9 million[6] - Branded Spirits sales declined by 3%[6] - Distilling Solutions sales decreased significantly by 43%[6] - Ingredient Solutions sales increased by 9%[6] - Adjusted EBITDA decreased by 29% to $32.3 million[6] - Adjusted EPS decreased by 34% to $0.85[6] - Year-to-date operating cash flows increased 26% to $92.5 million[6, 27] Segment Analysis - Branded Spirits premium plus sales increased 3% to $32.1 million, while value sales decreased 19% to $8.2 million[11] - Distilling Solutions sales decreased 50% to $28.5 million for brown goods[22] - Ingredient Solutions saw a sales increase of 5% to $17.0 million in specialty wheat starches and 15% to $8.9 million in specialty wheat proteins[23] Financial Guidance - The company raised full year adjusted EBITDA guidance to $110 million to $115 million[24] - The company raised full year adjusted basic EPS guidance to $2.60 to $2.75[24]

Chemed Corporation Overview - Chemed's Adjusted EBITDA margin was 20% in 2023[10, 18] - Chemed's Adjusted net income increased 13.8% from 2023 to 2024[10, 18] - Chemed's Adjusted diluted EPS from continuing operations increased 13.9% from 2023 to 2024[10, 18] Roto-Rooter - Roto-Rooter's service revenues and sales decreased by 5.2% from 2023 to 2024[10] - Roto-Rooter's adjusted net income decreased by 13.5% from 2023 to 2024[10] - Roto-Rooter's service revenues and sales were $900309 thousand in 2024[36] - Roto-Rooter's Adjusted EBITDA was $237087 thousand in 2024[36] VITAS Healthcare - VITAS's service revenues and sales increased by 16.4% from 2023 to 2024[10] - VITAS's adjusted net income increased by 38.9% from 2023 to 2024[10] - VITAS's revenues were $408 million in Q3 2025[47] - VITAS's net service revenue was $1530978 thousand in 2024[78]

CORPORATE PRESENTATION NORTH AMERICAN LEADER Structural Steel Fabrication Since 1956 ADF Group Inc. (October 29, 2025) Forging the future Acquisition of Métabetchouan, Saguenay -Lac Saint-Jean (QC) Corporate Presentation FORWARD LOOKING STATEMENTS This presentation contains forward-looking statements reflecting ADF's objectives and expectations. These statements are identified by the use of verbs such as "expects", "plans" or "anticipates" as well as by the use of future or conditional tenses. By their very ...

Financial Performance Highlights - Net income for Q3 2025 was $61.1 million, a 14.5% increase compared to Q2 2025 and a 15.8% increase compared to Q3 2024[9] - Core net income for Q3 2025 reached $63.3 million, up 17.9% from Q2 2025 and 19.8% from Q3 2024[9] - Return on average common equity was 22.5%, while core return on average tangible common equity was 25.5%[12] Income Statement Analysis - Net interest income was $92.7 million[9] - Non-interest income totaled $61.2 million, primarily driven by higher banking fees and increased foreign exchange revenue[9, 21] - Core non-interest expenses were $88.5 million, a decrease of 3.1% compared to the prior quarter[23] Balance Sheet Overview - Total assets amounted to $14.086 billion[26] - Total deposits reached $12.7 billion[26] - The loan-to-deposit ratio was 35%[53] Capital and Asset Quality - The bank's regulatory capital levels remain above minimum requirements[36] - Non-accrual loans were 2.0% of total loans[30] - Allowance for credit losses was $25.7 million, representing 0.6% of total loans[30] Interest Rate Sensitivity - Net unrealized losses on AFS securities improved to $101.5 million as of September 30, 2025[34] - Total investment portfolio duration decreased to 5.0 years[34]

Acquisition Overview - Cadre Holdings, Inc is acquiring TYR Tactical [3] - The total consideration for the acquisition is $175 million, including $150 million in cash and $25 million in CDRE stock [5] - TYR Tactical had $93 million in revenue in FY2024 [5] - Approximately 50% of TYR Tactical's revenue in 2024 is international [11] Strategic Rationale - The acquisition provides significant entry into new markets, particularly European military and defense [5] - TYR Tactical has a large geographic footprint, servicing 39 countries [11] - TYR Tactical offers the ability to manufacture plates/shields engineered with next-gen advanced materials [5] - The acquisition is expected to be immediately accretive to earnings and adj EBITDA margins [5] Proprietary IP & Manufacturing - TYR Tactical has secured 80 patents across the U S, Canada, UK, Australia, and Europe [17] - TYR Tactical has 59 registered trademarks [21]

Company Overview - Community Healthcare Trust (CHCT) is a REIT focused on healthcare properties[3] - As of September 30, 2025, CHCT had a market capitalization of $4356 million and an enterprise value of $9624 million[3] - The company has achieved dividend growth for 41 consecutive quarters[5] - CHCT's portfolio includes properties leased to approximately 315 tenants across 36 states[6,27] Financial Performance & Growth - CHCT has demonstrated consistent total asset growth since its IPO in 2015, with 590% growth[14,15] - The company has consistently increased its dividend each quarter since inception[16,17] - Healthcare spending accounted for 183% of US GDP in 2021 and is projected to reach $72 trillion by 2031, representing 197% of GDP[46] Investment Strategy & Portfolio - CHCT focuses on smaller, off-market or lightly marketed transactions to acquire properties at attractive yields[10,22] - The company is negotiating definitive purchase agreements for six properties with an aggregate expected purchase price of approximately $146 million and expected returns of 91% to 975%[26] - The portfolio is diversified by tenant, geography, healthcare facility type, and industry segment[22] - The top 3 tenants account for 212% of annualized rent[27] - The company maintains a conservative balance sheet, with debt to capitalization at 431% as of Q3 2025[55]

Q3 2025 Performance - Ryerson reported revenue of $1.16 billion, aligning with guidance, driven by a 2.6% increase in average selling prices, although tons shipped decreased by 3.2% compared to the prior quarter[11] - The company experienced a net loss of $14.8 million, resulting in a diluted loss per share of $0.46, while adjusted EBITDA, excluding LIFO, amounted to $40.3 million[13] - Ryerson's debt stood at $500 million, with net debt at $470 million, reflecting sequential decreases of $10 million and $9 million, respectively[13] - A fourth-quarter 2025 dividend of $0.1875 per share was declared[13] Q4 2025 Guidance - Shipments are expected to decline by 5% to 7% due to typical fourth-quarter seasonality and persisting demand challenges[16] - Average selling prices are projected to remain flat to increase by up to 2%, supported by the current tariff structure[16] Liquidity and Capital Management - Global liquidity remained strong at $521 million[21] - Net leverage of 3.7x in Q3 2025, remains above the target range of 0.5x to 2.0x[21] Financial Metrics (QoQ Comparison) - Net sales decreased by 0.7%[22] - Gross margin decreased by 70 bps[22] - Net loss increased by $16.7 million[22] - Diluted loss per share increased by $0.52[22] - Tons shipped decreased by 3.2%[22] - Adjusted EBITDA excluding LIFO decreased by $4.7 million[22] - Net debt decreased by $9 million[22]

Financial Highlights - Net sales reached $4.1 billion, a 2% increase organically[5] - Adjusted EPS was a record $2.13, up 5%[5] - The company repurchased approximately $150 million in shares[6] Segment Performance - Global Architectural Coatings net sales were $1.012 billion, with flat organic sales growth[13] - Performance Coatings net sales were $1.414 billion, with 2% organic sales growth[16] - Industrial Coatings net sales were $1.656 billion, with 4% organic sales growth[27] Aerospace Growth - Record quarterly aerospace coatings sales and earnings were achieved[5] - The company is investing over $0.5 billion to expand aerospace capabilities[22] - Aerospace net sales are expected to have a mid-single-digit to high-single-digit CAGR from 2025-2028[20] Balance Sheet and Cash Flow - Net debt stood at $5.4 billion as of September 30, 2025[30] - The cash balance was $1.9 billion as of September 30, 2025[30] - $310 million was deployed to shareholders through dividends and share repurchases in Q3 2025[30] 2025 Financial Projections - Full year 2025 adjusted EPS is projected to be $7.60 - $7.70 per share[31] - Full year 2025 organic sales are expected to grow at a low-single-digit rate[31] - Corporate expense (net of TSA) is projected to be $340 million - $350 million for full year 2025[31]